• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贲门失弛缓症中固有免疫和适应性免疫的失衡

Imbalance of Innate and Adaptive Immunity in Esophageal Achalasia.

作者信息

Yao Lu, Liu Zuqiang, Chen Weifeng, Xu Jiaqi, Xu Xiaoyue, Xu Jiaxin, Ma Liyun, Li Xiaoqing, Li Quanlin, Zhou Pinghong

机构信息

Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.

出版信息

J Neurogastroenterol Motil. 2023 Oct 30;29(4):486-500. doi: 10.5056/jnm21246. Epub 2023 Aug 16.

DOI:10.5056/jnm21246
PMID:37586778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577470/
Abstract

BACKGROUND/AIMS: Previous studies reveal that immune-mediated neuroinflammation plays a key role in the etiology of esophageal achalasia. However, the understanding of leucocyte phenotype and proportion is limited. This study aim to evaluate the phenotypes of leukocytes and peripheral blood mononuclear cells transcriptomes in esophageal achalasia.

METHODS

We performed high-dimensional flow cytometry to identified subsets of peripheral leukocytes, and further validated in lower esophageal sphincter histologically. RNA sequencing was applied to investigate the transcriptional changes in peripheral blood mononuclear cells of patients with achalasia. Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT) was used for estimating the immune cell types. A differential gene expression analysis was performed and the differential expressed genes were subjected to gene ontology, Kyoto Encyclopedia of Genes and Genomes network, protein-protein interaction network construction.

RESULTS

An imbalance between innate and adaptive immune cells occurred in achalasia. Specifically, neutrophils and CD8+ T cells increased both in peripheral blood and lower esophageal sphincter in achalasia. Eosinophils decreased in peripheral blood but massively infiltrated in lower esophageal sphincter. CIBERSORT analysis of peripheral blood mononuclear cells RNA sequencing displayed an increased prevalence of CD8+ T cells. 170 dysregulated genes were identified in achalasia, which were enriched in immune cells migration, immune response, etc. Proton pump inhibitor analysis revealed the intersections and gained 7 hub genes in achalasia, which were IL-6, Toll-like receptor 2, IL-1β, tumor necrosis factor, complement C3, and complement C1q A chain.

CONCLUSION

Patients with achalasia exhibited an imbalance of systematic innate and adaptive immunity, which may play an important role in the development of achalasia.

摘要

背景/目的:既往研究表明,免疫介导的神经炎症在贲门失弛缓症的病因中起关键作用。然而,对白细胞表型和比例的了解有限。本研究旨在评估贲门失弛缓症患者白细胞的表型及外周血单核细胞转录组。

方法

我们进行了高维流式细胞术以鉴定外周白细胞亚群,并在食管下括约肌进行组织学进一步验证。应用RNA测序研究贲门失弛缓症患者外周血单核细胞的转录变化。通过估计RNA转录本相对亚群进行细胞类型鉴定(CIBERSORT)来估计免疫细胞类型。进行差异基因表达分析,并对差异表达基因进行基因本体论、京都基因与基因组百科全书网络、蛋白质-蛋白质相互作用网络构建。

结果

贲门失弛缓症患者先天性和适应性免疫细胞之间出现失衡。具体而言,贲门失弛缓症患者外周血和食管下括约肌中的中性粒细胞和CD8 + T细胞均增加。外周血中嗜酸性粒细胞减少,但在食管下括约肌中大量浸润。外周血单核细胞RNA测序的CIBERSORT分析显示CD8 + T细胞的患病率增加。在贲门失弛缓症中鉴定出170个失调基因,这些基因在免疫细胞迁移、免疫反应等方面富集。质子泵抑制剂分析揭示了交集并在贲门失弛缓症中获得了7个枢纽基因,即IL-6、Toll样受体2、IL-1β、肿瘤坏死因子、补体C3和补体C1q A链。

结论

贲门失弛缓症患者表现出系统性先天性和适应性免疫失衡,这可能在贲门失弛缓症的发展中起重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/8f0159e8314b/jnm-29-4-486-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/d5d6b27e76c7/jnm-29-4-486-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/52f84ff07a94/jnm-29-4-486-f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/ab4693097b8d/jnm-29-4-486-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/b587daa5690c/jnm-29-4-486-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/44ce8638c5ab/jnm-29-4-486-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/01142cedcaf8/jnm-29-4-486-f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/8f0159e8314b/jnm-29-4-486-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/d5d6b27e76c7/jnm-29-4-486-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/52f84ff07a94/jnm-29-4-486-f2a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/ab4693097b8d/jnm-29-4-486-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/b587daa5690c/jnm-29-4-486-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/44ce8638c5ab/jnm-29-4-486-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/01142cedcaf8/jnm-29-4-486-f6a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/405d/10577470/8f0159e8314b/jnm-29-4-486-f7.jpg

相似文献

1
Imbalance of Innate and Adaptive Immunity in Esophageal Achalasia.贲门失弛缓症中固有免疫和适应性免疫的失衡
J Neurogastroenterol Motil. 2023 Oct 30;29(4):486-500. doi: 10.5056/jnm21246. Epub 2023 Aug 16.
2
A cross-sectional study reveals a chronic low-grade inflammation in achalasia.一项横断面研究揭示了贲门失弛缓症存在慢性低度炎症。
J Gastroenterol Hepatol. 2023 Apr;38(4):598-608. doi: 10.1111/jgh.16091. Epub 2023 Jan 8.
3
A single-cell transcriptional landscape of immune cells shows disease-specific changes of T cell and macrophage populations in human achalasia.单细胞转录组图谱显示人类贲门失弛缓症中 T 细胞和巨噬细胞群体的疾病特异性变化。
Nat Commun. 2023 Aug 4;14(1):4685. doi: 10.1038/s41467-023-39750-5.
4
An increased proportion of inflammatory cells express tumor necrosis factor alpha in idiopathic achalasia of the esophagus.在特发性食管贲门失弛缓症中,炎症细胞中表达肿瘤坏死因子α的比例增加。
Dis Esophagus. 2009;22(5):382-5. doi: 10.1111/j.1442-2050.2008.00922.x. Epub 2009 Jan 13.
5
Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis.PD1 和 TIM3 阻断可恢复急性酒精性肝炎患者的固有和适应性免疫。
Gastroenterology. 2015 Mar;148(3):590-602.e10. doi: 10.1053/j.gastro.2014.11.041. Epub 2014 Dec 2.
6
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.鉴定与检查点抑制剂诱导性心肌炎相关的致病性免疫细胞亚群。
Circulation. 2022 Jul 26;146(4):316-335. doi: 10.1161/CIRCULATIONAHA.121.056730. Epub 2022 Jun 28.
7
The nature of the myenteric infiltrate in achalasia: an immunohistochemical analysis.贲门失弛缓症中肌间浸润的性质:免疫组织化学分析
Am J Surg Pathol. 2000 Aug;24(8):1153-8. doi: 10.1097/00000478-200008000-00014.
8
Identification of human herpes virus 1 encoded microRNAs in biopsy samples of lower esophageal sphincter muscle during peroral endoscopic myotomy for esophageal achalasia.经口内镜下肌切开术治疗食管失弛缓症时,在下食管括约肌肌肉活检样本中鉴定人疱疹病毒 1 编码的 microRNAs。
Dig Endosc. 2020 Jan;32(1):136-142. doi: 10.1111/den.13491. Epub 2019 Oct 3.
9
Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation.贲门失弛缓症患者的食管下括约肌肌肉存在显著的肥大细胞脱颗粒现象。
Neurogastroenterol Motil. 2021 May;33(5):e14055. doi: 10.1111/nmo.14055. Epub 2020 Dec 6.
10
Differences in upper esophageal sphincter function and clinical characteristics among the three subtypes of Japanese patients with esophageal achalasia.三种亚型的日本贲门失弛缓症患者上食管括约肌功能和临床特征的差异。
Esophagus. 2022 Apr;19(2):316-323. doi: 10.1007/s10388-021-00897-z. Epub 2021 Dec 3.

引用本文的文献

1
The oesophagus as an immune organ.作为免疫器官的食管。
Nat Rev Gastroenterol Hepatol. 2025 Jun 18. doi: 10.1038/s41575-025-01086-4.
2
Megaoesophagus associated to inflammatory infiltrate in the autonomous plexus in a 7-year-old Spanish Water Dog.7 岁西班牙水犬的自主神经丛炎症浸润致巨食管症。
BMC Vet Res. 2024 Nov 29;20(1):534. doi: 10.1186/s12917-024-04399-9.
3
Association of circulating cytokine levels and tissue-infiltrating myeloid cells with achalasia: results from Mendelian randomization and validation through clinical characteristics and single-cell RNA sequencing.

本文引用的文献

1
Esophageal Dysmotility Is Associated With Disease Severity in Eosinophilic Esophagitis.食管动力障碍与嗜酸性粒细胞性食管炎的疾病严重程度相关。
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1719-1728.e3. doi: 10.1016/j.cgh.2021.11.002. Epub 2021 Nov 9.
2
Whole-exome sequencing reveals common and rare variants in immunologic and neurological genes implicated in achalasia.全外显子组测序揭示了免疫和神经基因中与贲门失弛缓症相关的常见和罕见变异。
Am J Hum Genet. 2021 Aug 5;108(8):1478-1487. doi: 10.1016/j.ajhg.2021.06.004. Epub 2021 Jun 30.
3
Achalasia: physiology and diagnosis.
循环细胞因子水平和组织浸润髓样细胞与贲门失弛缓症的关联:来自孟德尔随机化的结果,并通过临床特征和单细胞 RNA 测序进行验证。
J Gastroenterol. 2024 Dec;59(12):1079-1091. doi: 10.1007/s00535-024-02155-2. Epub 2024 Oct 8.
4
Deciphering the Immune Complexity of Esophageal Achalasia.解析贲门失弛缓症的免疫复杂性
J Neurogastroenterol Motil. 2023 Oct 30;29(4):405-406. doi: 10.5056/jnm23141.
贲门失弛缓症:生理学与诊断。
Ann N Y Acad Sci. 2020 Dec;1482(1):85-94. doi: 10.1111/nyas.14510. Epub 2020 Nov 2.
4
ACG Clinical Guidelines: Diagnosis and Management of Achalasia.ACG 临床指南:贲门失弛缓症的诊断与管理。
Am J Gastroenterol. 2020 Sep;115(9):1393-1411. doi: 10.14309/ajg.0000000000000731.
5
Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients With Eosinophilic Esophagitis.嗜酸性粒细胞性食管炎患者中并不少见贲门失弛缓症和动力性梗阻性疾病。
Clin Gastroenterol Hepatol. 2021 Aug;19(8):1554-1563. doi: 10.1016/j.cgh.2020.07.056. Epub 2020 Aug 4.
6
Multiplex immunoassays reveal increased serum cytokines and chemokines associated with the subtypes of achalasia.多重免疫分析显示血清细胞因子和趋化因子与贲门失弛缓症亚型相关增加。
Neurogastroenterol Motil. 2020 Jun;32(6):e13832. doi: 10.1111/nmo.13832. Epub 2020 Mar 5.
7
Hematological indices as indicators of silent inflammation in achalasia patients: A cross-sectional study.血液学指标作为贲门失弛缓症患者隐匿性炎症的指标:一项横断面研究。
Medicine (Baltimore). 2020 Feb;99(9):e19326. doi: 10.1097/MD.0000000000019326.
8
Neutrophils as emerging therapeutic targets.中性粒细胞:新兴的治疗靶点
Nat Rev Drug Discov. 2020 Apr;19(4):253-275. doi: 10.1038/s41573-019-0054-z. Epub 2020 Jan 22.
9
Mast cell infiltration associated with loss of interstitial cells of Cajal and neuronal degeneration in achalasia.贲门失弛缓症中与平滑肌细胞丢失和神经元退行性变相关的肥大细胞浸润。
Neurogastroenterol Motil. 2019 May;31(5):e13565. doi: 10.1111/nmo.13565. Epub 2019 Mar 13.
10
First genotype-phenotype study reveals HLA-DQβ1 insertion heterogeneity in high-resolution manometry achalasia subtypes.首次基因型-表型研究揭示高分辨率测压术贲门失弛缓症亚型中 HLA-DQβ1 插入的异质性。
United European Gastroenterol J. 2019 Feb;7(1):45-51. doi: 10.1177/2050640618804717. Epub 2018 Oct 3.